IDO1 expression can be either triggered as a counter regulatory response to cytokines like IL-1β and IL-6 released from tumor-infiltrating immune cells or maintained through tumor-intrinsic oncogenic signaling [71, 72]. The gene discussed is IL1B; the disease is neoplasm.